Health ministry questions reliability of vasculitis drug approval data ...Middle East

japan times - News
Tavneos was launched in Japan in 2022 after being approved by the ministry. Its package insert listed liver dysfunction as a serious side effect.

Hence then, the article about health ministry questions reliability of vasculitis drug approval data was published today ( ) and is available on japan times ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Health ministry questions reliability of vasculitis drug approval data )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News